DGAP-News: Apricus Biosciences Announces Korean Patent Approval for MycoVa(TM) for Nail Fungus
Apricus Biosciences, Inc.
03.10.2011 17:03
—————————————————————————
CEO Foresees Expanded Asian Patent Coverage for MycoVa(TM) Product
SAN DIEGO, 2011-10-03 17:03 CEST (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
(http://www.apricusbio.com) announced today that the Korean Patent Office will
grant a patent for MycoVa(tm), indicated for the treatment of onychomycosis
(commonly referred to as
